• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CODMAN & SHURTLEFF, INC. CODMAN PROGRAMMABLE VALVE SHUNT, CENTRAL NERVOUS SYSTEM & COMPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CODMAN & SHURTLEFF, INC. CODMAN PROGRAMMABLE VALVE SHUNT, CENTRAL NERVOUS SYSTEM & COMPS Back to Search Results
Catalog Number 82-3XXX
Device Problems Mechanical Problem (1384); Migration (4003)
Patient Problems Failure of Implant (1924); Neurological Deficit/Dysfunction (1982)
Event Type  Injury  
Manufacturer Narrative
Udi -- unknown part number, attempts to obtain product were unsuccessful, udi unavailable. Multiple attempts to obtain additional information were not successful; therefore a full evaluation could not be performed. Complaint sample was not returned to codman and no lot number information has been provided; therefore, an evaluation of the device could not be performed and manufacturing records could not be reviewed. The cause(s) of the difficulty reported by the customer could not be determined. If the complaint sample becomes available, this complaint will be reopened, and the respective evaluation performed. Trends will be monitored for this or similar complaints. At present, we consider this complaint to be closed.
 
Event Description
In the literature article ¿cervical compressive myelopathy caused by malfunction of a programmable cerebrospinal fluid shunt valve¿ by kota satoa, toru yamashitaa, keichiro tsunodaa, mami takemotoa, nozomi hishikawaa, jinwei shanga, yasuyuki ohtaa, ken kuwaharab, takao yasuharab, isao dateb, koji abea, published https://www. Sciencedirect. Com/science/article/pii/s2214751918300082?via%3dihub, it was reported that after implantation of an unknown chpv, the patient had overdrainage and neurologic "defitics", spinal cord damage, there was unexpected setting change of the valve, catheter migration after implant and device revision. Per the article: ¿a (b)(6) man with a dull headache visited a local neurosurgeon in (b)(6) 1998 and was diagnosed with idiopathic hydrocephalus. In (b)(6) 1998, a vp shunt operation was performed with a codman® hakim® programmable valve system (depuy synthes, raynham, ma, usa) (valve pressure, 160 mm h2o). The valve pressure increased to 180 mm h2o 1 month after surgery because of a persistent dull headache. However, 4 months after surgery, the valve pressure spontaneously changed from 180 to 160 mm h2o; however, he was doing fine. When the patient turned (b)(6), he developed intolerable abdominal pain, and abdominal x-rays revealed twisting of the intraperitoneal tube and reversal of the tip end position toward the head. He underwent abdominal surgery for revision of the distal intraperitoneal shunt tubing replacement, and his abdominal pain disappeared. At the age of (b)(6), the valve pressure spontaneously decreased again from 160 to 130 mm h2o; however, given that he was doing well no shunt setting changes was pursued. At the age of (b)(6), the patient newly developed bilateral tinnitus, bilateral hand numbness, and weakness in the left leg. At another local hospital, he underwent brain computed tomography (ct) that showed slit ventricles compared with the ventricles 2 years before, and without a change in valve pressure. However, the ventricles spontaneously enlarged and recovered again within 1 month. Therefore, he visited our hospital at the age of (b)(6). Upon admission to our hospital, the patient presented slight proximal muscle weakness in the upper and lower extremities (manual muscle test: r4+/l4). Muscle tonus of the left extremities was spastic with hyperreflexia. He had decreased superficial sensations in the left body and extremities. Laboratory data showed no abnormalities, and csf analysis revealed a low opening pressure (70 mm h2o) and an increase in protein (167 mg/dl) with a normal cell count (3/l). Peripheral nerve conduction was normal. Muscle electromyography in the upper extremities revealed chronic neurogenic change. Brain ct showed slightly enlarged lateral and third ventricles.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameCODMAN PROGRAMMABLE VALVE
Type of DeviceSHUNT, CENTRAL NERVOUS SYSTEM & COMPS
Manufacturer (Section D)
CODMAN & SHURTLEFF, INC.
325 paramount drive
raynham MA 02767
Manufacturer (Section G)
CODMAN & SHURTLEFF, INC.
325 paramount drive
raynham MA 02767
Manufacturer Contact
karen anigbo
11 cabot boulevard
mansfield, MA 02048
7819715608
MDR Report Key8016760
MDR Text Key125385103
Report Number1226348-2018-10772
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
NI
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation
Type of Report Initial
Report Date 10/09/2018
1 Device was Involved in the Event
0 Patients were Involved in the Event:
Date FDA Received10/29/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator
Device Catalogue Number82-3XXX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received10/09/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

-
-